Trials / Sponsors / OnKure, Inc.
OnKure, Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer Advanced Cancer, Breast Cancer, Advanced Solid Tumors | Phase 1 | 2024-02-26 |
| Completed | NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NR RAS Mutation, NRAS Gene Mutation, Melanoma | Phase 1 / Phase 2 | 2022-05-11 |
| Completed | A Study of OKI-179 in Patients With Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-05-08 |